首页 › 基金 › EMERALD ADVISERS, LLC › SYRE

EMERALD ADVISERS, LLC 对 SYRE 的持仓历史

SPYRE THERAPEUTICS INC · 医疗保健

EMERALD ADVISERS, LLC 在 Q3 2026 的 13F 申报中披露持有 SYRE(SPYRE THERAPEUTICS INC)571,047 股,市值约 US$50.8M,约占其申报组合的 1.40%,在其申报持仓中市值排名第 14 位。 EMERALD ADVISERS, LLC 最近 9 个申报季度中有 9 个季度披露了 SYRE 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)571.05K 股
申报持仓市值$50.84M
组合权重1.40%
首次申报Q3 2024
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

EMERALD ADVISERS, LLC 对 SYRE 的持仓演变

EMERALD ADVISERS, LLC 于 Q3 2024 首次披露 SYRE 持仓:292,569 股(约 US$8.6M)。 该持仓在 Q3 2026 达到峰值 571,047 股,市值约 US$50.8M。 在 9 次申报中,EMERALD ADVISERS, LLC 4 次增持、3 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 571,047 股、市值约 US$50.8M,环比增持 3,617 股。。 持仓曾出现大幅变动:Q4 2024 增持约 87% (随后一个季度股价下跌 31%)。

逐季持仓明细

季度股数金额变化
Q3 2024 292.57K $8.60M 新进
Q4 2024 546.79K $12.73M 增持
Q1 2025 547.83K $8.84M 持有
Q2 2025 565.86K $8.47M 增持
Q3 2025 548.71K $9.20M 减持
Q4 2025 636.11K $20.84M 增持
Q1 2026 613.37K $30.94M 减持
Q2 2026 567.43K $50.38M 减持
Q3 2026 571.05K $50.84M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SYRE 与 13F 数据

SYRE(SPYRE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 SYRE,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$383.5M), RTW INVESTMENTS, LP (US$377.5M), Paradigm Biocapital Advisors LP (US$341.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SYRE 的基金

查看 SYRE 的全部基金持有人 →

常见问题

How long has EMERALD ADVISERS, LLC held SYRE?

EMERALD ADVISERS, LLC has disclosed SYRE holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is EMERALD ADVISERS, LLC's current position in SYRE?

As of Q3 2026, EMERALD ADVISERS, LLC holds 571.05K shares of SYRE (SPYRE THERAPEUTICS INC), valued at $50.84M, representing 1.40% of its reported portfolio and ranking #14.

Has EMERALD ADVISERS, LLC been buying or selling SYRE?

In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in SYRE. The position peaked in Q3 2026 at 571.05K shares.

Which other funds hold SYRE?

Other major institutional holders of SYRE include PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.